Anatomy of success: Biotech firm lays groundwork for big 2022

Despite an up-and-down year, Catalyst Orthoscience appears poised for takeoff in the new year. One big aid? It has a product surgeons and patients alike love.

By Brian Hartz
| 12:00 p.m. December 30, 2021
| 0 Free Articles Remaining!

File. Catalyst Orthoscience CEO Brian Hutchison has more than 30 years of experience in the medical device industry.

Health Care

Breakthrough would be an apt term for the year Catalyst Orthoscience just experienced. The Naples-based medical device company, hot off winning FDA approval for its innovative new reverse shoulder implant system, closed a $12.5 million funding round that will help it acquire more inventory and hire staff it will need to drive sales in 2022.

“As tough as this year has been,” says CEO Brian Hutchison, “we've actually doubled revenue from (2020) and we think we can double it again in (2022).”